Biblio
Export 1170 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
“Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1261-1273, 2018.
, “Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1261-1273, 2018.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
, “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
, “Vitamin D and Memory Decline: Two Population-Based Prospective Studies.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1099-108, 2016.
, “Vitamin D Insufficiency and Cognitive Function Trajectories in Older Adults: The Rancho Bernardo Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 871-883, 2017.
, “Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 237-49, 2016.
, “Weight Loss and Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.
, “What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1295-1312, 2017.
, “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
, “When Patient Engagement and Research Ethics Collide: Lessons from a Dementia Forum.”, J Alzheimers Dis, vol. 59, no. 1, pp. 1-10, 2017.
, “White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 863-73, 2016.
, “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
, “White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
, “Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?”, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
, “Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.”, J Alzheimers Dis, vol. 54, no. 2, pp. 809-19, 2016.
, “δ Scores are Exportable Across Cultural and Linguistic Boundaries.”, J Alzheimers Dis, vol. 49, no. 2, pp. 561-70, 2016.
,